Boston Trust Walden Corp Sells 59,127 Shares of CorVel Corp. $CRVL

Boston Trust Walden Corp cut its stake in shares of CorVel Corp. (NASDAQ:CRVL) by 12.0% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 435,025 shares of the business services provider’s stock after selling 59,127 shares during the period. Boston Trust Walden Corp owned 0.85% of CorVel worth $23,774,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently made changes to their positions in the stock. Northwestern Mutual Wealth Management Co. acquired a new stake in shares of CorVel in the 3rd quarter valued at approximately $31,000. Los Angeles Capital Management LLC bought a new stake in CorVel during the fourth quarter worth $33,000. Quarry LP lifted its stake in CorVel by 218.6% in the third quarter. Quarry LP now owns 513 shares of the business services provider’s stock valued at $40,000 after acquiring an additional 352 shares during the last quarter. Eagle Bay Advisors LLC acquired a new stake in CorVel in the fourth quarter valued at $37,000. Finally, Rockefeller Capital Management L.P. grew its position in shares of CorVel by 66.9% in the 4th quarter. Rockefeller Capital Management L.P. now owns 574 shares of the business services provider’s stock valued at $39,000 after acquiring an additional 230 shares during the period. Institutional investors and hedge funds own 51.36% of the company’s stock.

Wall Street Analysts Forecast Growth

CRVL has been the topic of a number of research analyst reports. Weiss Ratings cut shares of CorVel from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, April 6th. Wall Street Zen raised CorVel from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has an average rating of “Sell”.

CorVel Price Performance

Shares of CorVel stock opened at $64.14 on Friday. The stock has a market capitalization of $3.27 billion, a price-to-earnings ratio of 29.97 and a beta of 0.98. CorVel Corp. has a twelve month low of $44.83 and a twelve month high of $103.06. The company has a 50-day simple moving average of $59.79 and a two-hundred day simple moving average of $59.19.

CorVel (NASDAQ:CRVL) last announced its earnings results on Tuesday, May 19th. The business services provider reported $0.61 EPS for the quarter. CorVel had a net margin of 11.51% and a return on equity of 29.92%. The company had revenue of $248.55 million for the quarter.

Insider Buying and Selling

In other CorVel news, insider Maxim Shishin sold 2,250 shares of the firm’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $60.59, for a total transaction of $136,327.50. Following the transaction, the insider owned 7,050 shares in the company, valued at $427,159.50. This trade represents a 24.19% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jeffrey J. Michael sold 9,000 shares of the company’s stock in a transaction on Tuesday, June 9th. The shares were sold at an average price of $60.98, for a total value of $548,820.00. Following the sale, the director owned 559,721 shares of the company’s stock, valued at approximately $34,131,786.58. The trade was a 1.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 13,249 shares of company stock valued at $807,126 over the last 90 days. 44.56% of the stock is owned by corporate insiders.

About CorVel

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).